For citations:
Kukurika A.V. DprE1 inhibitors – a prospective target for development of antituberculosis drugs. Tuberculosis and Lung Diseases. 2022;100(5):64-70. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-5-64-70
Kukurika A.V. DprE1 inhibitors – a prospective target for development of antituberculosis drugs. Tuberculosis and Lung Diseases. 2022;100(5):64-70. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-5-64-70